STERIS plc logo

STERIS plc (STE)

Market Open
1 Sep, 19:38
NYSE NYSE
$
229. 57
-3.07
-1.3196%
$
22.78B Market Cap
39.65 P/E Ratio
2.52% Div Yield
242,223 Volume
8.66 Eps
$ 232.64
Previous Close
Add Transaction
Day Range
228.96 234.5
Year Range
195.14 269.44
Want to track STE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

STE trading today lower at $229.57, a decrease of -1.3196% from yesterday's close, completing a monthly decrease of -0.5588% or -$1.29. Over the past 12 months, STE stock lost -9.2447%.
STE pays dividends to its shareholders, with the most recent payment made on Jun 26, 2026. The next announced payment will be in In 3 weeks on Sep 25, 2026 for a total of $0.69.
The last earnings report, released on May 20, 2026, missed the consensus estimates by -2.85%. On average, the company has fell short of earnings expectations by -1.7567%, based on the last three reports.
STERIS plc has completed 2 stock splits, with the recent split occurring on Aug 25, 1998.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on NYSE (USD).

STE Chart

People also search for

ABT
Abbott Laboratories
$ 108.88
-1.3411%
PFE
Pfizer Inc.
$ 28.52
+0.2108%
SYK
Stryker Corporation
$ 317.95
-1.8067%
CVS
CVS Health Corporation
$ 96.89
+3.1733%
MDT
Medtronic plc
$ 92.05
+1.5444%
Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?

STE is betting $600 million on a new chemistry center to boost capacity and efficiency, but higher spending and execution risks loom.

Zacks | 1 week ago
Should Investors Buy STERIS as Growth Meets Reasonable Valuation?

Should Investors Buy STERIS as Growth Meets Reasonable Valuation?

STE enters fiscal 2027 with solid growth, recurring healthcare demand and better margins, but tariffs and investment needs temper the valuation case.

Zacks | 1 week ago
STERIS Q1 Earnings Call Highlights

STERIS Q1 Earnings Call Highlights

STERIS NYSE: STE reported first-quarter fiscal 2027 revenue growth and higher earnings, while maintaining its full-year outlook and outlining a $600 million investment in a new chemistry manufacturing, research and distribution complex in North Carolina.

Marketbeat | 3 weeks ago

STERIS plc Investors

Name Quantity Cost Value Profit ($) Gain (%)
TJD
Thomas John Drogan PR Inc.IPAL SECURITIES Inc.
986 $249,976.15 $228,959.06 -$21,017.09 -8.41%
DI
David Izzi Brown, LISLE/CUMMINGS Inc.
2 $453 $456.8 $3.8 0.84%
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
570 $143,010.54 $132,644.71 -$10,365.83 -7.25%
BZ
Brandon Zatopek Commonwealth Equity Services LLC
5,808 $1.22M $1.38M $156,152.76 12.77%
PER
Paul E. Rasmussen SIT INVESTMENT ASSOCIATES Inc.
6,985 $1M $1.66M $661,178.45 65.93%

STERIS plc Analysts

Name Quantity Cost Value Profit ($) Gain (%)
Jason Bednar
Jason Bednar Piper Sandler
23.66 $5,618.05 $5,618.05 - -

STERIS plc (STE) FAQ

What is the stock price today?

The current price is $229.57.

On which exchange is it traded?

STERIS plc is listed on NYSE.

What is its stock symbol?

The ticker symbol is STE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.52%.

What is its market cap?

As of today, the market cap is 22.78B.

Has STERIS plc ever had a stock split?

STERIS plc had 2 splits and the recent split was on Aug 25, 1998.

STERIS plc Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Daniel A. Carestio CEO
NYSE Exchange
G8473T104 CUSIP
US Country
17,937 Employees
4 Sep 2026 Last Dividend
25 Aug 1998 Last Split
1 Jun 1992 IPO Date

Overview

STERIS plc is a leading global provider of infection prevention products and services. With its operations spanning across four main segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental, STERIS caters to a wide range of needs in the medical and pharmaceutical fields. From offering cleaning chemistries and sterilization products to providing comprehensive equipment management and maintenance services, the company stands as a vital player in the mission to maintain sterility and prevent infection worldwide. Founded in 1985 and headquartered in Dublin, Ireland, STERIS has built a robust presence around the globe, servicing hospitals, healthcare providers, and pharmaceutical manufacturers with its innovative solutions and services.

Products and Services

  • Healthcare Segment

    Provides a variety of products and services essential for sterile processing departments and operating rooms. This includes cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, and lights, among other capital equipment. STERIS also offers comprehensive equipment management services, including installation, maintenance, upgrade, repair, and troubleshooting, as well as preventive maintenance programs, instrument, and endoscope repair and maintenance, and consulting for process improvement.

  • Applied Sterilization Technologies Segment

    Offers contract sterilization and testing services to medical device and pharmaceutical manufacturers. With around 50 contract sterilization and laboratory facilities, STERIS supports clients by ensuring their products meet strict sterility standards through a variety of sterilization methods.

  • Life Sciences Segment

    Focused on the design, manufacturing, and sale of consumable products like formulated cleaning chemistries, and equipment including sterility assurance products, sterilizers, and washer disinfectors. Similar to the Healthcare segment, the Life Sciences division provides equipment installation, maintenance, upgrade, and repair services, alongside preventive maintenance and repair services tailored for the life sciences industry.

  • Dental Segment

    Delivers a range of products for dental offices including hand and electric-powered dental instruments, infection control products, personal protective equipment, and water quality products. These offerings are aimed at enhancing infection prevention practices within the dental suite, ensuring safety and compliance in dental care operations.

Contact Information

Address: 5960 Heisley Road
Phone: 353 1 232 2000